logo

HCWB

HCW Biologics·NASDAQ
--
--(--)
--
--(--)
3.64 / 10
Netural

Fund flow data show a split: small and medium inflows lean positive (inflow ratios ~0.51-0.52), while large and extra-large blocks trend negative (inflow ratios ~0.47-0.49). The overall fund flow score is 7.28/10, deemed good, reflecting liquidity support for smaller players. Analyst sentiment is overwhelmingly bullish with a Strong Buy rating from one coverage provider, yet historical win rate is 0%, underscoring unreliability. Combined, liquidity is improving for nimble traders, but institutional skepticism and poor historical analyst accuracy warrant caution.

FundamentalSentiment(3.64)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

100%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2025-05-29
InstitutionMaxim Group
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for HCWB?
  • HCWB holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.64/10 (Netural).